๐
Stock screener
Nasdaq Stock Screener
S&P 500 Stock Screener
OTC Stock Screener
Best Growth Stocks
Low P/E stocks
Founder-led companies
EV Stocks
Airline Stocks
Blue Chip Stocks
๐
Market
Discover
Stocks with high potential upside
Biggest stock gainers today
Biggest stock losers today
Stock Market Today
U.S. Stock Market Holiday
Calendars
Earnings Calendar
S&P 500 Earnings Calendar
Nasdaq Earnings Calendar
Dow Jones Earnings Calendar
Tech Earnings Calendar
Banks Earnings Calendar
Directories
Stocks
Key executives
Wall Street Analysts
๐
Academy
New
Alternative data
Interviews
๐ฆ
Hedge funds
New
Sign in
Sign up
๐
Stock screener
๐
Market
๐
Academy
New
๐ฆ
Hedge funds
New
Sign in
Sign up
Home
Stocks
SELB
Patents, Design & Utilities
Selecta Biosciences
Patents, Design & Utilities
Last updated:
6 Sep 2025
List of all Selecta Biosciences patents
25 in total
All
Design
Utility application
Utility grant
Status
Patent
Filling date
Issue date
Application
Utility:
METHODS AND COMPOSITIONS FOR REDUCING IMMUNE RESPONSES AGAINST IMMUNOGLOBULIN PROTEASES
External link
Filling date:
6 Sep 2025
Issue date:
5 May 2022
4 Nov 2021
5 May 2022
Grant
Utility:
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
External link
Filling date:
6 Sep 2025
Issue date:
12 Apr 2022
11 Jun 2019
12 Apr 2022
Application
Utility:
METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
External link
Filling date:
6 Sep 2025
Issue date:
10 Mar 2022
24 Mar 2021
10 Mar 2022
Grant
Utility:
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
External link
Filling date:
6 Sep 2025
Issue date:
1 Feb 2022
6 Aug 2018
1 Feb 2022
Application
Utility:
METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS
External link
Filling date:
6 Sep 2025
Issue date:
7 Oct 2021
11 Mar 2021
7 Oct 2021
Application
Utility:
METHODS AND COMPOSITIONS USING SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT
External link
Filling date:
6 Sep 2025
Issue date:
23 Sep 2021
26 Feb 2021
23 Sep 2021
Application
Utility:
FORMULATIONS AND DOSES OF PEGYLATED URICASE
External link
Filling date:
6 Sep 2025
Issue date:
24 Jun 2021
6 Nov 2020
24 Jun 2021
Application
Utility:
METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASES AND DISORDERS
External link
Filling date:
6 Sep 2025
Issue date:
27 May 2021
21 Oct 2020
27 May 2021
Application
Utility:
FORMULATIONS AND DOSES OF PEGYLATED URICASE
External link
Filling date:
6 Sep 2025
Issue date:
24 Dec 2020
4 Jun 2020
24 Dec 2020
Application
Utility:
METHODS AND COMPOSITIONS FOR ATTENUATED ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSE
External link
Filling date:
6 Sep 2025
Issue date:
17 Dec 2020
28 May 2020
17 Dec 2020
Application
Utility:
NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
External link
Filling date:
6 Sep 2025
Issue date:
17 Dec 2020
27 Jan 2020
17 Dec 2020
Application
Utility:
METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS
External link
Filling date:
6 Sep 2025
Issue date:
19 Nov 2020
28 Apr 2020
19 Nov 2020
Application
Utility:
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN
External link
Filling date:
6 Sep 2025
Issue date:
19 Nov 2020
24 Apr 2020
19 Nov 2020
Grant
Utility:
Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
External link
Filling date:
6 Sep 2025
Issue date:
2 Jun 2020
2 May 2014
2 Jun 2020
Application
Utility:
METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE
External link
Filling date:
6 Sep 2025
Issue date:
16 Apr 2020
26 Aug 2019
16 Apr 2020
Application
Utility:
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
External link
Filling date:
6 Sep 2025
Issue date:
2 Apr 2020
4 Sep 2019
2 Apr 2020
Application
Utility:
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS
External link
Filling date:
6 Sep 2025
Issue date:
2 Apr 2020
8 Aug 2019
2 Apr 2020
Application
Utility:
METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY
External link
Filling date:
6 Sep 2025
Issue date:
12 Mar 2020
11 Jun 2019
12 Mar 2020
Application
Utility:
METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES
External link
Filling date:
6 Sep 2025
Issue date:
5 Mar 2020
6 Jun 2019
5 Mar 2020
Application
Utility:
METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
External link
Filling date:
6 Sep 2025
Issue date:
5 Mar 2020
13 May 2019
5 Mar 2020
Application
Utility:
METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS
External link
Filling date:
6 Sep 2025
Issue date:
6 Feb 2020
16 Jul 2019
6 Feb 2020
Application
Utility:
METHODS AND COMPOSITIONS OF OTC CONSTRUCTS AND VECTORS
External link
Filling date:
6 Sep 2025
Issue date:
6 Feb 2020
16 Jul 2019
6 Feb 2020
Grant
Utility:
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
External link
Filling date:
6 Sep 2025
Issue date:
15 Oct 2019
27 Jul 2015
15 Oct 2019
Grant
Utility:
Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
External link
Filling date:
6 Sep 2025
Issue date:
8 Oct 2019
2 May 2014
8 Oct 2019
Grant
Utility:
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
External link
Filling date:
6 Sep 2025
Issue date:
24 Sep 2019
27 Jul 2015
24 Sep 2019
Showing
1
to
25
of
25
patents.
1